U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY
Go back to U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY| Harmony Metals, Inc. Common (NASDAQ: HRMY) | Delayed: 42.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.74 | 52 Week High | $1.35 | |||
| Open | $42.59 | 52 Week Low | $0.10 | |||
| Day High | $43.01 | P/E | N/A | |||
| Day Low | $42.10 | EPS | $0.00 | |||
| Volume | 1,610 | |||||
